The University of Chicago Header Logo

Phase 2 study of ABT-751 in patients with refractory metastatic colorectal carcinoma (CRC).

Phase 2 study of ABT-751 in patients with refractory metastatic colorectal carcinoma (CRC). J Clin Oncol. 2005 Jun; 23(16_suppl):3537.

View in: PubMed